Table 4 The effect of RAPS on ADL specific to PD (Models A1–3 N = 128; Models B1–3 N = 130)

OR (95% CI)

OR (95% CI)

OR (95% CI)

OR (95% CI)

OR (95% CI)

OR (95% CI)

RAPS, T1

1.07 (1.00–1.13)*

1.06 (1.00–1.13)*

1.50 (1.09–2.06)*

1.06 (1.00–1.13)*

1.07 (1.00–1.13)*

1.29 (0.9–1.84)

Functional limitations, T1

2.03 (1.56–2.65)***

1.91 (1.46–2.50)***

1.98 (1.49–2.63)***

2.05 (1.58–2.67)***

2.08 (1.57–2.75)***

2.14 (1.59–2.88)***

External HCB, T1

1.05 (1.00–1.10)*

1.35 (1.06–1.71)**

RAPS*External HCB

0.99 (0.99–1.00)*

GSE, T1

0.89 (0.81–0.96)**

1.09 (0.74–1.6)

RAPS*GSE

0.99 (0.98–1.01)

R square

0.32

0.34

0.37

0.32

0.36

0.37